Vol. I · Issue 01 · Spring MMXXVI

Cornerstone Peptides

Custom Peptide Synthesis · Analytical-Grade Supply

Regulatory · In Preparation

The 2026 HHS Category 1 Reclassification: Implications for Compounding Pharmacies

Currently in preparation — expected Q2 2026.

A plain-language read of the reclassification and what it changes for compounding-pharmacy supply.

Receive a notification when this article publishes.

One email when it goes live. No list, no noise.

← All of the Knowledge Center